Skip to main content
48°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
3
Next >
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
Tags
Investing
Business News
U/S/ Markets
From
CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
Apple Inc
Mad Money
Eli Lilly and Co
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
AstraZeneca PLC
U/S/ Markets
stocks
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Wells Fargo & Co
Delta Air Lines Inc
Business News
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Social issues
AstraZeneca PLC
Biotechnology
From
CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
December 22, 2023
Tags
Biotech and Pharmaceuticals
Goldman Sachs Group Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios
December 18, 2023
Tags
Stock markets
stocks
Investment Strategy
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
Seagen Inc
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
Jim Cramer explains why it's hard to be bullish on the healthcare sector
November 30, 2023
Tags
Mad Money
Johnson & Johnson
Cigna Corp
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
ON Semiconductor Corp
Comcast Corp
CNBC Investing Club
From
CNBC.com News
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
October 26, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Cramer's Lightning Round: Sell Fisker
October 23, 2023
Tags
S&P 500
Mad Money
Fisker Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 23, 2023
Tags
Coca/Cola Co
General Motors Co
Ford Motor Co
From
CNBC.com News
Top Wall Street analysts favor these five dividend stocks during tumultuous times
October 22, 2023
Tags
Chesapeake Energy Corp
Bristol/Myers Squibb Co
Civitas Resources Inc
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Health care industry
Novartis AG
Johnson & Johnson
From
CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
Tags
Medicare health plans
Medicare Part D
Johnson & Johnson
From
CNBC.com News
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
September 27, 2023
Tags
Health care industry
Johnson & Johnson
Biotech and Pharmaceuticals
From
CNBC.com News
Top Wall Street analysts are bullish on these dividend stocks
September 24, 2023
Tags
Bristol/Myers Squibb Co
Weekend Brief
Investment strategy
From
CNBC.com News
Judge withdraws from Medicare drug price case after stock ownership is revealed
September 01, 2023
Tags
Business
Health & Science
Breaking News: Business
From
CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
Tags
Biotechnology
AstraZeneca PLC
Law and Regulation
From
CNBC.com News
5 things to know before the stock market opens Wednesday
August 30, 2023
Tags
Business News
Meta Platforms Inc
Economy
From
CNBC.com News
Here are the three most used drugs on the Medicare price negotiation list
August 29, 2023
Tags
Johnson & Johnson
Health care industry
Bristol/Myers Squibb Co
From
CNBC.com News
Biden administration unveils first 10 drugs subject to Medicare price negotiations as it moves to cut costs
August 29, 2023
Tags
Health & Science
Business News
US: News
From
CNBC.com News
Why startups are investing millions to make drugs and semiconductors in space
August 20, 2023
Tags
Merck & Co Inc
Pfizer Inc
Bristol/Myers Squibb Co
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Merck & Co Inc
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
July 18, 2023
Tags
Lawsuits
Business
Pharmaceuticals
From
CNBC.com News
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
June 30, 2023
Tags
Business News
Breaking News: Business
Health & Science
From
CNBC.com News
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
June 21, 2023
Tickers
LAW
LAWS
Tags
Law
Johnson & Johnson
Health care industry
From
CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
June 20, 2023
Tags
US: News
Social issues
Health & Science
From
CNBC.com News
As the market starts to cool down, Cramer says don't be afraid to stay bullish
June 03, 2023
Tags
NIO Inc
Mad Money
Apple Inc
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.